摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3-aminopyrazin-2-yl)(4-chlorophenyl)methanone | 1188410-06-1

中文名称
——
中文别名
——
英文名称
(3-aminopyrazin-2-yl)(4-chlorophenyl)methanone
英文别名
(3-amino-pyrazin-2-yl)-(4-chloro-phenyl)-methanone;(3-aminopyrazin-2-yl)-(4-chlorophenyl)methanone
(3-aminopyrazin-2-yl)(4-chlorophenyl)methanone化学式
CAS
1188410-06-1
化学式
C11H8ClN3O
mdl
——
分子量
233.657
InChiKey
JPPGVSVJDZOKDS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    68.9
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (3-aminopyrazin-2-yl)(4-chlorophenyl)methanone吡啶盐酸 、 palladium diacetate 、 tetra-N-butylammonium tribromide 、 caesium carbonateR-(+)-1,1'-联萘-2,2'-双二苯膦一水合肼 作用下, 以 乙醇氯仿乙二醇甲苯 为溶剂, 反应 11.5h, 生成 2-benzyl-8-(4-chlorobenzyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one
    参考文献:
    名称:
    New red-shifted coelenterazine analogues with an extended electronic conjugation
    摘要:
    A new promising approach to the development of red-shifted coelenterazine analogues was described. In order to alter the photochemical properties of native coelenterazine, we have designed and synthesized analogues bearing a new electron-rich structure. The spectroscopic results obtained, in the presence of the target enzyme (Renilla Luciferase), show a bathochromic emission shift of the entire class of new derivatives. Among them, the 2-benzyl-8-(4-chlorophenylthio)-6-(4-hydroxyphenyl)imidazo[1,2-a]pyrazin-3(7H)-one (8) shows an emission at 510 nm and uncommon slow kinetic decay. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2012.07.041
  • 作为产物:
    描述:
    (4-chlorophenyl)(3-chloropyrazin-2-yl)methanone 作用下, 以 正丁醇 为溶剂, 反应 0.5h, 以83%的产率得到(3-aminopyrazin-2-yl)(4-chlorophenyl)methanone
    参考文献:
    名称:
    New red-shifted coelenterazine analogues with an extended electronic conjugation
    摘要:
    A new promising approach to the development of red-shifted coelenterazine analogues was described. In order to alter the photochemical properties of native coelenterazine, we have designed and synthesized analogues bearing a new electron-rich structure. The spectroscopic results obtained, in the presence of the target enzyme (Renilla Luciferase), show a bathochromic emission shift of the entire class of new derivatives. Among them, the 2-benzyl-8-(4-chlorophenylthio)-6-(4-hydroxyphenyl)imidazo[1,2-a]pyrazin-3(7H)-one (8) shows an emission at 510 nm and uncommon slow kinetic decay. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2012.07.041
点击查看最新优质反应信息

文献信息

  • Organic compounds
    申请人:BRUCE Ian
    公开号:US20090239847A1
    公开(公告)日:2009-09-24
    The present invention concerns a compound of formula (I) or a salt, suitably a pharmaceutically acceptable salt, or solvate thereof, wherein the groups R 1 , R 2 , Ar′, A and Y are defined in the description, to compositions and use of the compounds in the treatment of inflammatory and allergic conditions.
    本发明涉及一种化合物,其化学式为(I)或其盐,适宜为药用可接受的盐,或其溶剂化合物,其中基团R1、R2、Ar′、A和Y在描述中有定义,以及该化合物在治疗炎症和过敏症状中的应用。
  • Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme
    申请人:Novartis AG
    公开号:US08268834B2
    公开(公告)日:2012-09-18
    The present invention concerns a compound of formula (I) or a salt, suitably a pharmaceutically acceptable salt, or solvate thereof, wherein the groups R1, R2, Ar′, A and Y are defined in the description, to compositions and use of the compounds in the treatment of inflammatory and allergic conditions.
    本发明涉及化合物公式(I)或其盐,适宜的是药学上可接受的盐或其溶剂,其中基团R1、R2、Ar'、A和Y在说明中定义,以及该化合物在治疗炎症和过敏症状中的组成和用途。
  • Organic Compounds
    申请人:Bruce Ian
    公开号:US20120214800A1
    公开(公告)日:2012-08-23
    The present invention concerns a compound of formula (I) or a salt, suitably a pharmaceutically acceptable salt, or solvate thereof, wherein the groups R 1 , R 2 , Ar′, A and Y are defined in the description, to compositions and use of the compounds in the treatment of inflammatory and allergic conditions.
    本发明涉及公式(I)的化合物或其盐,适当地为药学上可接受的盐或其溶剂,其中组R1,R2,Ar′,A和Y在说明中定义,以及该化合物在治疗炎症和过敏症状中的组合物和用途。
  • PYRIDINES AND PYRAZINES AS INHIBITORS OF PI3K
    申请人:Novartis AG
    公开号:EP2257529A2
    公开(公告)日:2010-12-08
  • US8268834B2
    申请人:——
    公开号:US8268834B2
    公开(公告)日:2012-09-18
查看更多